Nephro-Urology Monthly

Published by: Kowsar

Effects of Pretreatment With Single-Dose or Intermittent Oxygen on Cisplatin-Induced Nephrotoxicity in Rats

Bahram Rasoulian 1 , 2 , Ayat Kaeidi 1 , Soheila Pourkhodadad 1 , * , Omid Dezfoulian 3 , Maryam Rezaei 1 , Hannaneh Wahhabaghai 4 and Masoud Alirezaei 5
Authors Information
1 Razi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, IR Iran
2 Department of Physiology and Pharmacology, Lorestan University of Medical Sciences, Khorramabad, IR Iran
3 Department of Pathobiology, School of Veterinary Medicine, Lorestan University, Khorramabad, IR Iran
4 Urology Research Center, Tehran University of Medical Sciences, Tehran, IR Iran
5 Division of Biochemistry, School of Veterinary Medicine, Lorestan University, Khorramabad, IR Iran
Article information
  • Nephro-Urology Monthly: September 01, 2014, 6 (5); e19680
  • Published Online: September 5, 2014
  • Article Type: Research Article
  • Received: April 24, 2014
  • Revised: May 29, 2014
  • Accepted: June 14, 2014
  • DOI: 10.5812/numonthly.19680

To Cite: Rasoulian B, Kaeidi A, Pourkhodadad S, Dezfoulian O, Rezaei M, et al. Effects of Pretreatment With Single-Dose or Intermittent Oxygen on Cisplatin-Induced Nephrotoxicity in Rats, Nephro-Urol Mon. 2014 ; 6(5):e19680. doi: 10.5812/numonthly.19680.

Abstract
Copyright © 2014, Nephrology and Urology Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Livingston RB. Cisplatin in the treatment of solid tumors: effect of dose and schedule. J National Cancer Inst. 1989; 81(10): 724-5
  • 2. Pabla N, Dong Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int. 2008; 73(9): 994-1007
  • 3. Yao X, Panichpisal K, Kurtzman N, Nugent K. Cisplatin nephrotoxicity: a review. Am J Med Sci. 2007; 334(2): 115-24
  • 4. Santoso JT, Lucci JA, Coleman RL, Schafer I, Hannigan EV. Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial. Cancer Chemother Pharmacol. 2003; 52(1): 13-8
  • 5. Saleh S, El‐Demerdash E. Protective effects of L-arginine against cisplatin-induced renal oxidative stress and toxicity: role of nitric oxide Basic Clin Pharmacol Toxicol. 2005; 97(2): 91-7
  • 6. Nisar S, Feinfeld DA. N-acetylcysteine as salvage therapy in cisplatin nephrotoxicity. Renal Failure. 2002; 24(4): 529-33
  • 7. Sener G, Satiroglu H, Kabasakal L, Arbak S, Oner S, Ercan F, et al. The protective effect of melatonin on cisplatin nephrotoxicity. Fundam Clin Pharmacol. 2000; 14(6): 553-60
  • 8. Appenroth D, Frob S, Kersten L, Splinter FK, Winnefeld K. Protective effects of vitamin E and C on cisplatin nephrotoxicity in developing rats. Arch Toxicol. 1997; 71(11): 677-83
  • 9. Ali BH, Al Moundhri MS. Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research. Food Chem Toxicol. 2006; 44(8): 1173-83[DOI][PubMed]
  • 10. Beiranvand A, Rasoulian B, Alirezaei M, Hashemi P, Pilevarian AA, Ezatpour B, et al. Pretreatment with Olive Leaf Extract partially attenuates cisplatin-induced nephrotoxicity in rats. Yafteا. 2010; 11(5): 35-44
  • 11. Karimi G, Khouei A, Omidi A, Kalantari M, Babaei J, Taghiabadi E, et al. Protective effect of aqueous and ethanolic extracts of Portulaca oleracea against cisplatin induced nephrotoxicity. Iran J Basic Med Sci. 2010; 3(2): 31-5
  • 12. Rasoulian B, Jafari M, Mahbod M, Dehaj ME, Nowrozi M, Wahhabaghai H, et al. Pretreatment with oxygen protects rat kidney from cisplatin nephrotoxicity. Renal Failure. 2010; 32(2): 234-42
  • 13. Bigdeli MR, Hajizadeh S, Froozandeh M, Heidarianpour A, Rasoulian B, Asgari AR, et al. Normobaric hyperoxia induces ischemic tolerance and upregulation of glutamate transporters in the rat brain and serum TNF-alpha level. Exp Neurol 2008; 212(2): 298-306
  • 14. Bigdeli MR, Hajizadeh S, Froozandeh M, Rasulian B, Heidarianpour A, Khoshbaten A. Prolonged and intermittent normobaric hyperoxia induce different degrees of ischemic tolerance in rat brain tissue. Brain Res. 2007; 1152: 228-33
  • 15. Esmaili Dehaj M, Baharvand B, Rasoulian B, Foadaddini M, Asgari A, Noroozzadeh A, et al. Delayed protective effects of hyperoxia against cardiac arrhythmias and infarction in anesthetized rats. J Surg Res. 2009; 151(1): 55-61
  • 16. Foadoddini M, Esmailidehaj M, Mehrani H, Sadraei SH, Golmanesh L, Wahhabaghai H, et al. Pretreatment with hyperoxia reduces in vivo infarct size and cell death by apoptosis with an early and delayed phase of protection. Eur J Cardiothorac Surg. 2011; 39(2): 233-40
  • 17. Rasoulian B, Mohammadhosseniakbari H, Kadkhodaee M, Mofid M, Baqeri G, Bigdeli MR, et al. Preconditioning with oxygen attenuates rat renal ischemia-reperfusion injury J Surg Res. 2008; 146(2): 282-8
  • 18. Wahhabaghai H, Rasoulian B, Esmaili M, Mehrani HA, Mohammadhosseniakbari H, Mofid M, et al. Hyperoxia-induced protection against rat's renal ischemic damage: relation to oxygen exposure time. Ren Fail. 2009; 31(6): 514-21
  • 19. Dong H, Xiong L, Zhu Z, Chen S, Hou L, Sakabe T. Preconditioning with hyperbaric oxygen and hyperoxia induces tolerance against spinal cord ischemia in rabbits. Anesthesiology. 2002; 96(4): 907-12
  • 20. Nie H, Xiong L, Lao N, Chen S, Xu N, Zhu Z. Hyperbaric oxygen preconditioning induces tolerance against spinal cord ischemia by upregulation of antioxidant enzymes in rabbits. J Cereb Blood Flow Metab 2006; 26(5): 666-74
  • 21. Yu SY, Chiu JH, Yang SD, Yu HY, Hsieh CC, Chen PJ, et al. Preconditioned hyperbaric oxygenation protects the liver against ischemia-reperfusion injury in rats. J Surg Res. 2005; 128(1): 28-36
  • 22. Liu Y, Sun XJ, Liu J, Kang ZM, Deng XM. Heme oxygenase-1 could mediate the protective effects of hyperbaric oxygen preconditioning against hepatic ischemia–reperfusion injury in rats. Clin Exp Pharmacol Physiol. 2011; 38(10): 675-82
  • 23. Saini U, Gumina RJ, Wolfe B, Kuppusamy ML, Kuppusamy P, Boudoulas KD. Preconditioning mesenchymal stem cells with caspase inhibition and hyperoxia prior to hypoxia exposure increases cell proliferation J Cell Biochem. 2013; 114(11): 2612-23
  • 24. Einollahi B, Poor-Reza-Gholi F, Rezaeean S, Jahani Y, Nafar M, Najafizadeh K, et al. Deceased-donor hyperoxia deteriorates kidney graft function Transpl Int. 24(2)-8
  • 25. Montazeri K, Vakily M, Honarmand A, Kashefi P, Safavi M, Taheri S, et al. Short-time intermittent preexposure of living human donors to hyperoxia improves renal function in early posttransplant period: a double-blind randomized clinical trial. J Transplant. 2011; 2011: 204843
  • 26. Rostami Z, Einollahi B, Ghadiani MH. Does living donor hyperoxia have an impact on kidney graft function after transplantation? Nephrourol Mon 2013; 5(3): 835-9
  • 27. Tahep ld P, Valen G, Starkopf J, Kairane C, Zilmer M, Vaage J. Pretreating rats with hyperoxia attenuates ischemia-reperfusion injury of the heart. Life Sci. 2001; 68(14): 1629-40
  • 28. Bigdeli MR, Rasoulian B, Meratan AA. In vivo normobaric hyperoxia preconditioning induces different degrees of antioxidant enzymes activities in rat brain tissue. Eur J Pharmacol. 2009; 611(1-3): 22-9[DOI][PubMed]
  • 29. Baharvand B, Dehaj ME, Foadaddini M, Rasoulian B, Poorkhalili K, Aghai HW, et al. Delayed cardioprotective effects of hyperoxia preconditioning prolonged by intermittent exposure. J Surg Res. 2010; 160(1): 53-9
  • 30. Tinits P. Oxygen therapy and oxygen toxicity. Ann Emerg Med. 1983; 12(5): 321-8
  • 31. Alirezaei M, Kheradmand A, Heydari R, Tanideh N, Neamati S, Rashidipour M. Oleuropein protects against ethanol-induced oxidative stress and modulates sperm quality in the rat testis. Mediterr J Nutr Metab 2012; 5(3): 205-11
  • 32. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193(1): 265-75
  • 33. Alirezaei M, Jelodar G, Niknam P, Ghayemi Z, Nazifi S. Betaine prevents ethanol-induced oxidative stress and reduces total homocysteine in the rat cerebellum. J Physiol Biochem. 2011; 67(4): 605-12
  • 34. Claiborne A. CRC handbook of methods for oxygen radical research: CRC Press; 1985;
  • 35. Subbarao KV, Richardson JS, Ang LC. Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro. J Neurochem. 1990; 55(1): 342-5
  • 36. Miller RP, Tadagavadi RK, Ramesh G, Reeves WB. Mechanisms of cisplatin nephrotoxicity. Toxins. 2010; 2(11): 2490-518
  • 37. Greger R, Windhorst U. Comprehensive Human Physiology: From Cellular Mechanisms to Integration 1996;
  • 38. Kaeidi A, Rasoulian B, Hajializadeh Z, Pourkhodadad S, Rezaei M. Cisplatin toxicity reduced in human cultured renal tubular cells by oxygen pretreatment. Renal Failure. 2013; 35(10): 1382-6
  • 39. Saadat A, Shariat Maghani SS, Rostami Z, Davoudi A, Davoudi F, Shafie A, et al. Normobaric hyperoxia preconditioning ameliorates cisplatin nephrotoxicity. Renal Failure. 2014; 36(1): 5-8
  • 40. Bigdeli MR, Hajizadeh S, Froozandeh M, Rasulian B, Heidarianpour A, Khoshbaten A. Prolonged and intermittent normobaric hyperoxia induce different degrees of ischemic tolerance in rat brain tissue. Brain Res. 2007; 1152: 228-33
  • 41. Aydinoz S, Uzun G, Cermik H, Atasoyu EM, Yildiz S, Karagoz B, et al. Effects of different doses of hyperbaric oxygen on cisplatin-induced nephrotoxicity. Renal Failure. 2007; 29(3): 257-63[DOI][PubMed]
  • 42. Atasoyu EM, Yildiz S, Bilgi O, Cermik H, Evrenkaya R, Aktas S, et al. Investigation of the role of hyperbaric oxygen therapy in cisplatin-induced nephrotoxicity in rats. Arch Toxicol. 2005; 79(5): 289-93[DOI][PubMed]
  • 43. Tavafi M, Ahmadvand H, Goodarzi S, Rasoulian B. Investigating the Effect of Pretreatment with Oxygen on Inhibition of Gentamycin-induced Nephrotoxicity in Rats. SSUJ. 2013; 21(4): 523-32
  • 44. Lieberthal W, Triaca V, Levine J. Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis. Am J Physiol Renal Physiol. 1996; 270(4)
  • 45. Ramesh G, Reeves WB. Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-alpha Kidney Int. 2004; 65(2): 490-9
  • 46. Soltani N, Nematbakhsh M, Eshraghi-Jazi F, Talebi A, Ashrafi F. Effect of Oral Administration of Magnesium on Cisplatin-Induced Nephrotoxicity in Normal and Streptozocin-Induced Diabetic Rats. Nephro Urol Mon. 2013; 5(4): 884
  • 47. Eshraghi-Jazi F, Nematbakhsh M, Nasri H, Talebi A, Haghighi M, Pezeshki Z, et al. The protective role of endogenous nitric oxide donor (L-arginine) in cisplatin-induced nephrotoxicity: Gender related differences in rat model. J Res Med Sci 2011; 16(11): 1389-96
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments